Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
Cumberland Pharmaceuticals announced the closing of a $100 million strategic transaction with Apotex, involving Apotex's acquisition of Cumberland's b...
Cumberland Pharmaceuticals announced the closing of a $100 million strategic transaction with Apotex, involving Apotex's acquisition of Cumberland's b...